Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of DocGo Inc (NASDAQ: DCGO) closed at $2.82 in the last session, up 1.81% from day before closing price of $2.77. In other words, the price has increased by $1.81 from its previous closing price. On the day, 0.73 million shares were traded. DCGO stock price reached its highest trading level at $2.86 during the session, while it also had its lowest trading level at $2.74.
Ratios:
We take a closer look at DCGO’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.22 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.32. For the most recent quarter (mrq), Quick Ratio is recorded 2.50 and its Current Ratio is at 2.50. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Deutsche Bank on February 28, 2025, Downgraded its rating to Hold and sets its target price to $2.85 from $5 previously.
On August 18, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.
On April 21, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.Cantor Fitzgerald initiated its Overweight rating on April 21, 2023, with a $11 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 17 ’24 when Etalvina Leite bought 16,500 shares for $4.33 per share.
Leite Etalvina sold 16,500 shares of DCGO for $71,610 on Dec 17 ’24. The Director now owns 51,411 shares after completing the transaction at $4.34 per share. On Dec 16 ’24, another insider, Tendler Ely D, who serves as the General Counsel and Secretary of the company, sold 23,088 shares for $4.44 each. As a result, the insider received 102,511 and left with 175,645 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DCGO now has a Market Capitalization of 287592064 and an Enterprise Value of 249797712. As of this moment, DocGo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.28, and their Forward P/E ratio for the next fiscal year is 45.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.47 while its Price-to-Book (P/B) ratio in mrq is 0.90. Its current Enterprise Value per Revenue stands at 0.405 whereas that against EBITDA is 5.604.
Stock Price History:
The Beta on a monthly basis for DCGO is 1.10, which has changed by -0.30541873 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, DCGO has reached a high of $5.68, while it has fallen to a 52-week low of $2.63. The 50-Day Moving Average of the stock is -31.06%, while the 200-Day Moving Average is calculated to be -24.16%.
Shares Statistics:
According to the various share statistics, DCGO traded on average about 795.75K shares per day over the past 3-months and 911250 shares per day over the past 10 days. A total of 101.91M shares are outstanding, with a floating share count of 86.68M. Insiders hold about 15.01% of the company’s shares, while institutions hold 47.94% stake in the company. Shares short for DCGO as of 1741910400 were 6542790 with a Short Ratio of 9.69, compared to 1739491200 on 6556114. Therefore, it implies a Short% of Shares Outstanding of 6542790 and a Short% of Float of 6.5.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of DocGo Inc (DCGO) involves the perspectives of 2.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.03, with high estimates of $0.12 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.8 and $0.0 for the fiscal current year, implying an average EPS of $0.4. EPS for the following year is $0.82, with 2.0 analysts recommending between $1.12 and $0.51.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $105.27M. It ranges from a high estimate of $123.88M to a low estimate of $84.4M. As of the current estimate, DocGo Inc’s year-ago sales were $192.09MFor the next quarter, 7 analysts are estimating revenue of $100.13M. There is a high estimate of $106.38M for the next quarter, whereas the lowest estimate is $87.3M.
A total of 7 analysts have provided revenue estimates for DCGO’s current fiscal year. The highest revenue estimate was $430.05M, while the lowest revenue estimate was $365M, resulting in an average revenue estimate of $413.44M. In the same quarter a year ago, actual revenue was $616.56MBased on 5 analysts’ estimates, the company’s revenue will be $447.41M in the next fiscal year. The high estimate is $466.46M and the low estimate is $418.8M.
